Discrimination between mono- and trimethylated cap structures by two isoforms of Caenorhabditis elegans eIF4E

被引:35
作者
Miyoshi, H
Dwyer, DS
Keiper, BD
Jankowska-Anyszka, M
Darzynkiewicz, E
Rhoads, RE [1 ]
机构
[1] Louisiana State Univ, Ctr Hlth Sci, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA
[2] Louisiana State Univ, Ctr Hlth Sci, Dept Psychiat, Shreveport, LA 71130 USA
[3] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland
[4] Univ Warsaw, Dept Biophys, PL-02093 Warsaw, Poland
关键词
Caenorhabditis elegans; cap recognition; molecular dynamics; trans-splicing; 2,2,7-trimethylguanosine;
D O I
10.1093/emboj/cdf473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Primitive eukaryotes like Caenorhabditis elegans produce mRNAs capped with either m(7)GTP or m(3)(2,2,7)GTP. Caenorhabditis elegans also expresses five isoforms of the cap-binding protein eIF4E. Some isoforms (e.g. IFE-3) bind to m(7)GTP-Sepharose exclusively, whereas others (e.g. IFE-5) bind to both m(7)GTP- and m(3)(2,2,7)GTP-Sepharose. To examine specificity differences, we devised molecular models of the tertiary structures of IFE-3 and IFE-5, based on the known structure of mouse eIF4E-1. We then substituted amino acid sequences of IFE-5 with homologous sequences from IFE-3. As few as two changes (N64Y/V65L) converted the cap specificity of IFE-5 to essentially that of IFE-3. Molecular dynamics simulations suggested that the width and depth of the cap-binding cavity were larger in IFE-5 than in IFE-3 or the N64Y/V65L variant, supporting a model in which IFE-3 discriminates against m(3)(2,2,7)GTP by steric hindrance. Furthermore, the affinity of IFE-5 (but not IFE-3) for m(3)(2,2,7)GTP was reversibly increased when thiol reagents were removed. This was correlated with the formation of a disulfide bond between Cys-122 and Cys-126. Thus, translation of m(3)(2,2,7)GTP-capped mRNAs may be regulated by intracellular redox state.
引用
收藏
页码:4680 / 4690
页数:11
相关论文
共 47 条
[1]  
ALTMANN M, 1989, J BIOL CHEM, V264, P12145
[2]  
Amiri A, 2001, DEVELOPMENT, V128, P3899
[3]  
Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt
[4]  
480::AID-BIES6&gt
[5]  
3.0.CO
[6]  
2-Q
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   Mass spectrometric analysis of the N terminus of translational initiation factor eIF4G-1 reveals novel isoforms [J].
Bradley, CA ;
Padovan, JC ;
Thompson, TL ;
Benoit, CA ;
Chait, BT ;
Rhoads, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :12559-12571
[9]  
BROWNING KS, 1987, J BIOL CHEM, V262, P11228
[10]   Quantitative assessment of mRNA cap analogues as inhibitors of in vitro translation [J].
Cai, A ;
Jankowska-Anyszka, M ;
Centers, A ;
Chlebicka, L ;
Stepinski, J ;
Stolarski, R ;
Darzynkiewicz, E ;
Rhoads, RE .
BIOCHEMISTRY, 1999, 38 (26) :8538-8547